| There are more than 8,000 kinds of ethnic medicinal materials in China,accounting for more than 70% of the total medicinal resources in China,and more than 600 kinds of ethnomedicinal products,belonging to more than 40 different ethnic cultural systems,which are extremely rich in biodiversity and cultural diversity.However,at the present stage of development of ethnic medicine,there are problems such as confusion in the base source and inconsistent standards;no standards for some herbs in the varieties of patent medicines and hospital preparations,and the phenomenon of inversion;inconsistent plant species origin of some herbs after translation from minority languages into Chinese,which may cause misuse;and inconsistent preparation specifications.C.grandiflora is a customary local species and a common herb among the Miao people.Domestic research institutions have only conducted preliminary studies on the chemical composition and pharmacological effects,and no research has been reported on the quality standard of Chinese herbal medicine.Due to the lack of legal quality standards,it restricts the clinical promotion of C.grandiflora as Chinese herbal medicine and Chinese herbal drinks for medical institutions,which are not conducive to the development of new products and industrialization.In order to deepen the excavation of Honghe prefecture characteristic herbs,ethnic special effects of medicine,to protect the health of the people,through the test,research,declaration work,the Honghe prefecture characteristic herbs "C.grandiflora" through the State Drug Administration for the record,so that it can be included in the Yunnan Province drug standards catalog,and in the implementation of this project project risk management.This paper mainly takes the research project of C.grandiflorapharmaceutical quality standard as an example to analyze the risks in the process of ethnic medicine standard research.According to the idea of raising the question,analyzing the problem and solving the problem,the structure is divided into sections of introduction,related concepts,analysis of risk sources and key control points,risk control,conclusion and outlook.That is,the problem is presented and in-depth,so as to propose targeted and operable policy recommendations.In this paper,the concepts involved in risk management are briefly introduced,and then five problems in the process of risk management of the C.grandiflora drug quality standard project are studied,and the necessity of risk management is also briefly discussed.Built on the above study,several means of hazard factor identification are explored and analyzed.Based on this,several sources of risk generation are linked,and the right prevention strategies are proposed: identifying the species base source by professionals,developing industry norms for planting and harvesting,exchanging experience in learning methods for identifying and handling wild fava bean roots,improving the development and updating of the standard system,and strengthening the training of inspection personnel.In this way,management countermeasures can be found in the analysis of risks,so as to achieve the maximum benefit and better guarantee the completion of the project.Featured herbs into the legal standards,which is an important support to protect people’s health,is an important means to ensure the safe and effective use of medicinal herbs,to promote the development of local specialty herbal cultivation industry and in depth development of ethnic medicine peripheral products have the role of escort to protect;for the future to include more ethnic medicine into the legal standards has a horse’s mouth significance. |